Showing results (31-40 of 339) with videos related to

Sort By:
Pageof 34
Drug Safety|October 9, 2009
A benefit-risk assessment of imatinib in chronic myeloid leukaemia and gastrointestinal stromal tumoursDominik Wolf, Holger Rumpold
Deutsche Medizinische Wochenschrift (1946)|March 15, 2022
[What's new in myeloproliferative neoplasia?]Stefan Schmidt, Dominik Wolf
Expert Review of Hematology|November 19, 2010
Role of gene-expression profiling in chronic myeloid leukemiaStefan Schmidt, Dominik Wolf
Oncotarget|December 12, 2018
Correction: Molecular response prediction in CML: novel ideas?Dominik Wolf, Sieghart Sopper
Deutsche Medizinische Wochenschrift (1946)|November 2, 2023
[Recent findings in myelodysplastic syndrome]Verena Petzer, Dominik Wolf
Lung Cancer (Amsterdam, Netherlands)|July 27, 2021
Deregulated glutamate to pro-collagen conversion is associated with adverse outcome in lung cancer and may be targeted by renin-angiotensin-aldosterone system (RAS) inhibitionFlorian Kocher, Piotr Tymoszuk, Arno Amann, et al.
JTO Clinical and Research Reports|July 2, 2026
Trastuzumab Deruxtecan Induces Complete Pathological Response in Oligometastatic HER2-Mutant NSCLC: Case ReportLaurenz Nagl, Lena Horvath, Arno Amann, et al.
Atherosclerosis|September 6, 2016
Endothelial cell metabolism: A novel player in atherosclerosis? Basic principles and therapeutic opportunitiesAndreas Pircher, Lucas Treps, Natalia Bodrug, et al.
Cancer Biology & Therapy|February 12, 2011
Targeting the insulin-like growth factor network in cancer therapyIsabel Heidegger, Andreas Pircher, Helmut Klocker, et al.
Oncology Research and Treatment|March 22, 2018
Anti-Angiogenics: Their Value in Colorectal Cancer TherapyAndreas Seeber, Eberhard Gunsilius, Günther Gastl, et al.
Pageof 34